VTN and neoplasm: Our recent related work has shown that complement component C3 and other complement proteins accumulate in tumours treated by PDT (Cecic and Korbelik, 2002; Cecic et al, 2005), and that complement system recognises PDT-treated tumour cells as their target (Cecic et al, 2006).